MarketCapExport financials
Insmed Incorporated (INSM)
The export includes the complete available history of financial statements and ratios. Numbers are provided in full, without million or billion abbreviations, in their original reporting units.
CSV downloads as a ZIP archive with one file for each report and frequency.
Facebook
X
Telegram
Insmed Incorporated Income Statement 2025-2008 | INSM
Brief overview of revenue and earnings at Insmed Incorporated
The figures are compared over a five-year interval. Revenue reported by Insmed Incorporated was 164 million dollars at the beginning of the period and 606 million dollars at the end. Across the full period, sales moved by +268.8%; the average annual rate was 29.8%. This pace points to rapid expansion of the business.
Gross profit was $125 million at the start and $483 million at the end of the period (+288.2%). Direct costs grew more slowly than revenue and improved the economics of sales. Comparing the endpoints gives gross margins of 75.7% and 79.7%. The margin shift points to a more favorable sales-and-cost structure.
Over the period, EBITDA shifted from −$256 million to −$1.2 billion, a change of −382.7%. EBITDA underperformed the top-line trend. EBITDA margin was −155.8% at the start and −203.9% at the end. The margin contraction indicates weaker operating efficiency.
The final result was −294 million dollars initially and −1.3 billion dollars in the final year. Profitability deteriorated further over the five years.
The five-year change in capitalization reached +805.9%: from 3.5 billion dollars to 31.6 billion dollars. Investor expectations increased faster than reported performance.
Financial takeaway
Signs of deterioration dominate the five-year picture. Key strengths include better sales economics and a larger revenue base. The main areas of concern are declining net profitability, pressure on operating profitability and a low EBITDA margin. Further direction will depend on top-line growth, operating profitability, and net income.
Annual Income Statement Insmed Incorporated
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Market Cap |
31.6 B | 13.7 B | 3.82 B | 2.48 B | 2.68 B | 3.49 B | 1.76 B | 1.91 B | 1.75 B | 869 M | 774 M | 666 M | 731 M | 162 M | 113 M | 105 M | 216 K | - |
Shares |
199 M | 164 M | 140 M | 123 M | 112 M | 97.6 M | 84.6 M | 76.9 M | 66.6 M | 61.9 M | 58.6 M | 43.1 M | 35 M | 26.5 M | 23.3 M | 13.2 M | 12.7 K | - |
Historical Prices |
159 | 83.3 | 27.2 | 20.2 | 23.9 | 35.8 | 24.9 | 29.6 | 24.2 | 15.9 | 12.2 | 18.5 | 20 | 6.16 | 4.26 | 7.9 | 17 | 5.7 |
Net Income |
-1.28 B | -914 M | -750 M | -482 M | -435 M | -294 M | -254 M | -324 M | -193 M | -176 M | -118 M | -79.2 M | -56.1 M | -41.4 M | -59.7 M | -6.43 M | 118 M | - |
Revenue |
606 M | 364 M | 305 M | 245 M | 188 M | 164 M | 136 M | 9.84 M | - | - | - | - | 11.5 M | - | 4.42 M | 6.92 M | 10.4 M | - |
Cost of Revenue |
123 M | 85.7 M | 65.6 M | 55.1 M | 44.2 M | 39.9 M | 24.2 M | 2.42 M | - | - | - | - | - | - | - | - | - | - |
Gross Profit |
- | - | - | - | - | - | 112 M | 7.41 M | - | - | - | - | - | - | 4.42 M | - | - | - |
Operating Income |
-1.25 B | -878 M | -710 M | -457 M | -375 M | -265 M | -235 M | -307 M | -189 M | -173 M | -117 M | -87.4 M | -55 M | -42.4 M | -61.7 M | -8.09 M | -8.67 M | - |
Interest Expense |
83.8 M | 84.9 M | 81.7 M | 26.4 M | 40.5 M | 29.6 M | 27.7 M | 25.5 M | 5.92 M | 3.5 M | 2.89 M | 2.42 M | 2.41 M | 763 K | 10 K | 109 K | 781 K | - |
EBITDA |
-1.24 B | -872 M | -704 M | -452 M | -366 M | -256 M | -230 M | -306 M | -186 M | -171 M | -116 M | -86.3 M | -54.3 M | -41.9 M | -35.4 M | -8.04 M | -7.97 M | - |
Operating Expenses |
- | - | - | - | - | - | 348 M | 315 M | 189 M | 173 M | 117 M | 87.4 M | 66.5 M | 42.4 M | 40.1 M | 15 M | 19 M | - |
General and Administrative Expenses |
701 M | 461 M | 345 M | 266 M | 234 M | 204 M | 211 M | 168 M | 46.2 M | 35.3 M | 30.6 M | 23 M | 22.2 M | 12.7 M | - | 10.3 M | 9.84 M | - |
Annual performance
Select metrics to display
All numbers in USD currency
Quarterly Income Statement Insmed Incorporated
| 2026-Q2 | 2026-Q1 | 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Shares |
217 M | 215 M | 212 M | 189 M | 181 M | 179 M | 174 M | 155 M | 148 M | 148 M | 143 M | 138 M | 136 M | 136 M | 121 M | 120 M | 119 M | 119 M | 117 M | 110 M | 103 M | 103 M | 102 M | 96.6 M | 89.8 M | 89.7 M | 89.2 M | 81.8 M | 77.5 M | 77.3 M | 77.1 M | 76.8 M | 76.6 M | 76.6 M | 65.3 M | 62.2 M | 62 M | 62 M | 61.9 M | 61.9 M | 61.9 M | 61.8 M | 61.8 M | 60.8 M | 50 M | 49.8 M | 44.1 M | 39.3 M | 39.2 M | 39.1 M | 37.4 M | 31.8 M | 31.6 M | 31.5 M | 25 M | 24.9 M | 24.9 M | 24.8 M | 24.8 M | 24.8 M | 18.8 M |
Net Income |
-13.2 M | -164 M | -370 M | -322 M | -257 M | - | -221 M | -301 M | -157 M | - | -159 M | -245 M | -160 M | - | -131 M | -95.6 M | -94.6 M | - | -113 M | -117 M | -91.6 M | - | -63.7 M | -61.9 M | -66.4 M | -53 M | -60.7 M | -66.5 M | -74.2 M | -91.6 M | -87.7 M | -76.4 M | -68.5 M | -65.4 M | -45.2 M | -44.7 M | -37.4 M | -68.4 M | -37.8 M | -36.6 M | -33.5 M | -31.2 M | -31 M | -28.6 M | -27.4 M | -17.6 M | -24 M | -23.2 M | -14.3 M | -16.2 M | -17.3 M | -8.85 M | -13.7 M | -15.5 M | -9.38 M | -9.7 M | -6.84 M | -8.16 M | -34.6 M | -10 M | -6.89 M |
Revenue |
425 M | 306 M | 142 M | 107 M | 92.8 M | - | 93.4 M | 90.3 M | 75.5 M | - | 79.1 M | 77.2 M | 65.2 M | - | 67.7 M | 65.2 M | 53.1 M | - | 46.8 M | 45.4 M | 40.2 M | - | 43.6 M | 42.5 M | 36.9 M | 45.7 M | 38.9 M | 30 M | 21.9 M | 9.84 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 11.5 M | - | - | - | - | - | 1.4 M | 435 K | 978 K | 1.6 M |
Cost of Revenue |
67.2 M | 47.4 M | 29.4 M | 28.1 M | 21.3 M | - | 21.2 M | 21 M | 17.5 M | - | 16.7 M | 16.6 M | 13.8 M | - | 13.5 M | 16.4 M | 12.2 M | - | 10.2 M | 10.8 M | 9.84 M | - | 10.6 M | 9.95 M | 8.44 M | - | 6.44 M | 4.92 M | 4.15 M | 2.42 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Gross Profit |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 33 M | 32.5 M | 28.4 M | 37 M | 32.4 M | 25.1 M | 17.8 M | 7.41 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Income |
-1.55 M | -153 M | -366 M | -313 M | -248 M | - | -213 M | -289 M | -146 M | - | -148 M | -236 M | -148 M | - | -128 M | -88.3 M | -89.8 M | - | -104 M | -88.6 M | -83.8 M | - | -56.2 M | -54.1 M | -60.4 M | -47.1 M | -56.5 M | -62.2 M | -69.5 M | -87.7 M | -84 M | -72.9 M | -62.8 M | -65.4 M | -44.1 M | -43.5 M | -36 M | -67.1 M | -37.1 M | -36.1 M | -33.1 M | -32.6 M | -30.2 M | -28 M | -26.7 M | -23.1 M | -23.4 M | -22.8 M | -18.1 M | -15.6 M | -16.8 M | -8.27 M | -14.3 M | -15.8 M | -9.35 M | -9.98 M | -7.26 M | -8.87 M | -35 M | -10.5 M | -7.42 M |
Interest Expense |
-531 K | -736 K | -603 K | 21.2 M | 21.6 M | - | 21.1 M | 21.3 M | 21 M | - | 20.3 M | 20.6 M | 20 M | - | 3.35 M | 3.36 M | 3.29 M | - | 11.2 M | 10.3 M | 7.56 M | - | 7.18 M | 7.47 M | 7.41 M | - | 6.85 M | 6.78 M | 6.73 M | - | 6.68 M | 6.49 M | 5.64 M | - | 1.5 M | 1.49 M | 1.47 M | - | 769 K | 624 K | 622 K | - | 725 K | 718 K | 722 K | - | 594 K | 595 K | 606 K | - | 525 K | 635 K | 643 K | - | 222 K | 1 K | 2 K | - | 2 K | 3 K | 4 K |
EBITDA |
4.56 M | -150 M | -359 M | -312 M | -246 M | - | -212 M | -288 M | -144 M | - | -146 M | -234 M | -147 M | - | -126 M | -87.1 M | -88.5 M | - | -96.6 M | -87.3 M | -81.4 M | - | -49.4 M | -49.6 M | -58.1 M | -47.1 M | -53.2 M | -59.9 M | -68.4 M | -87.7 M | -81.3 M | -71.2 M | -62 M | -65.4 M | -41.9 M | -42.1 M | -35.3 M | -67.1 M | -35.4 M | -35.1 M | -32.6 M | -32.6 M | -28.9 M | -27.1 M | -26.3 M | -23.1 M | -22.7 M | -22.5 M | -17.9 M | -15.6 M | -16.4 M | -7.97 M | -14.2 M | -15.8 M | -8.94 M | -9.71 M | -7.13 M | -8.87 M | -34.7 M | -10.3 M | -7.34 M |
Operating Expenses |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 84 M | 72.9 M | 62.8 M | - | 44.1 M | 43.5 M | 36 M | - | 37.1 M | 36.1 M | 33.1 M | - | 30.2 M | 28 M | 26.7 M | - | 23.4 M | 22.8 M | 18.1 M | - | 16.8 M | 19.8 M | 14.3 M | - | 9.35 M | 9.98 M | 7.26 M | - | 35.4 M | 11.5 M | 9.02 M |
General and Administrative Expenses |
247 M | 247 M | 186 M | 155 M | 148 M | - | 119 M | 107 M | 93.1 M | - | 90.6 M | 84.4 M | 79.9 M | - | 75.6 M | 60 M | 56.7 M | - | 60.3 M | 57.2 M | 51.6 M | - | 46.6 M | 49.7 M | 51.3 M | - | 53.3 M | 52.4 M | 54.8 M | - | 44.4 M | 37.2 M | 32.7 M | - | 17.4 M | 16.6 M | 13.7 M | - | 13.7 M | 12.3 M | 12.5 M | - | 11 M | 9.71 M | 9.54 M | - | 8.2 M | 7.87 M | 6.73 M | - | 4.75 M | 7.54 M | 3.98 M | - | 3.65 M | 2.24 M | 2.52 M | - | 2.47 M | 2.74 M | 3.26 M |
Quarterly performance
Select metrics to display
All numbers in USD currency
The income statement is one of the three key financial reports of a company Insmed Incorporated (alongside the balance sheet and the cash flow statement). It shows how the company makes money and what its expenses are:
- How much revenue the company earned
- How much it spent on production, personnel, marketing, taxes, etc.
- What profit remained in the end
Analyzing the income statement helps an investor understand whether the business generates stable and growing profits, how effectively the company controls its expenses, and whether it is capable of generating income in the future. Additionally, this analysis shows how the company copes with crises and economic cycles, and allows assessing the potential for stock price growth and dividend payments.
Features- The income statement may include both recurring and one-time items (for example, profit from the sale of assets). It is necessary to separate core metrics from one-off events for accurate analysis.
- Companies often publish interim reports (e.g., quarterly), which allows for more timely tracking of trends.
- A combined analysis of the income statement with the balance sheet and cash flow statement provides a comprehensive view of the company’s financial health.
USA
Canada
Niderland
France
Israel
Australia
Britain
